MARY-COLLEEN MILLAGE: Open Payments
NPI 1588992200 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,345 in 83 payments from 24 companies in 2025. Trend: 2023 $1,357 · 2024 $1,370 · 2025 $1,345
Food & beverage: $1,345
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $212 |
| PFIZER INC. | 11 | $200 |
| AstraZeneca Pharmaceuticals LP | 6 | $159 |
| ABBVIE INC. | 12 | $146 |
| Lilly USA, LLC | 8 | $128 |
| Abbott Laboratories | 3 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $58 |
| Inspire Medical Systems, Inc. | 2 | $43 |
| Medtronic, Inc. | 1 | $26 |
Products named: Wegovy, FARXIGA, NURTEC ODT, MOUNJARO, Ozempic, UBRELVY, FREESTYLE LIBRE 3, XIFAXAN.
Industry payments across VA — which companies pay providers there.
